- ACE inhibitors, sartans, or in the treatment of hypertension: unnecessary controversy?2014 | Third Faculty of Medicine
- Sartans and ACE inhibitors in the treatment of hypertension2014 | Third Faculty of Medicine
- Angiotensin receptor blockers in the treatment of arterial hypertension?2005 | First Faculty of Medicine
- Zarethan in the treatment of hypertension2008 | Third Faculty of Medicine
- Sartany v léčbě hypertenze2015 | Third Faculty of Medicine
- Sartan associated enteropathy - case report and review of the literature2016 | Faculty of Medicine in Hradec Králové
- Inhibitory ACE versus sartany v léčbě primární hypertenze2016 | Third Faculty of Medicine
- Sartany a inhibitory ACE - souboj titánů nebo souboj o léčbu v duchu EBM?2013 | Third Faculty of Medicine
- Kombinace inhibitoru ACE a sartanu není u pacientů s diabetickou nefropatií více renoprotektivní než monoterapie sartanem a má více nežádoucích účinků : komentář2014 | First Faculty of Medicine
- The role of angiotensin II type 1 receptor blockers (sartans) in the prevention of cardiovascular disease2005 | Faculty of Medicine in Pilsen
- Current position of a fixed combination telmisartan with amlodipine in treatment of essential arterial hypertension2016 | Third Faculty of Medicine
- Léčba hypolipidemiky a antihypertenzivy2018 | First Faculty of Medicine
- Clinical experience with a fixed combination of candesartan 32 mg and hydrochlorothiazide2013 | Third Faculty of Medicine
- Nová doporučení pro diagnostiku a léčbu hypertenze2018 | First Faculty of Medicine
- Angiotensin converting enzyme inhibitors and angiotensin II AT1 receptor antagonists (sartans) used in the secondary prevention of cardiovascular events, comparison of basic data2010 | Third Faculty of Medicine
- Latest developments in the management of resistant hypertension2018 | First Faculty of Medicine
- Is it worth changing therapy in achieving targets?2013 | First Faculty of Medicine
- Proteinuria +22017 | First Faculty of Medicine
- Pharmacological management of chornic heart failure2010 | Faculty of Medicine in Hradec Králové
- Novinky v léčbě rezistentní hypertenze2019 | First Faculty of Medicine
- Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial2008 | First Faculty of Medicine
- AT1-blockers in the treatment of hypertension: summary2016 | First Faculty of Medicine
- Blockade of the renin-angiotensin-aldosteron system (RAAS) in secondary cardiovascular prevention2009 | First Faculty of Medicine
- Aliskiren, renin inhibitor, new hope for patients in diabetic nephropathy2009 | First Faculty of Medicine
- Contribution of aliskiren therapy in diabetic patients in Czech republic2009 | First Faculty of Medicine
- Aliskiren in the treatment of cardiovascular disease. Preliminary resulst of ALTITUDE study.2012 | First Faculty of Medicine
- Candesartan in the therapy of vascular diseases2012 | Third Faculty of Medicine
- Treatment of hypertension in diabetes mellitus2009 | First Faculty of Medicine